Skip to main navigation
Skip to search
Skip to main content
UK Health Security Agency Main
Search content at UK Health Security Agency
Main
Profiles
Research units
Projects
Research output
Prizes
Activities
Impacts
Adulterants in illicit drugs: A review of empirical evidence
Claire Cole
, Lisa Jones
, Jim McVeigh
*
, Andrew Kicman
, Qutubuddin Syed
, Mark Bellis
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Review article
›
peer-review
231
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Adulterants in illicit drugs: A review of empirical evidence'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Illicit Drugs
100%
Adulterants
100%
Heroin
42%
Adulteration
28%
Circulation of Information
28%
Scotland
14%
Public Health Risk
14%
Evidence-based
14%
Complex Interactions
14%
Ultra-low Dose
14%
Cocaine
14%
Drug Delivery
14%
Paracetamol
14%
Health Problems
14%
Life-threatening
14%
Health Risk
14%
Anthrax
14%
Minimal Impact
14%
Bacillus Species
14%
Injectable Drugs
14%
Public Perception
14%
Serious Illness
14%
Supply-demand
14%
Bacterial Contaminants
14%
Tangible Impacts
14%
Clostridium Species
14%
Strategic Analysis
14%
Supply Control
14%
Pharmacological Effects
14%
Forensic Toxicology
14%
User Health
14%
Clinical Toxicology
14%
Fentanyl
14%
Adulterated
14%
Caffeine
14%
Manufacturing Methods
14%
Procaine
14%
Pharmacology, Toxicology and Pharmaceutical Science
Diamorphine
100%
Paracetamol
33%
Clostridium
33%
Anthrax
33%
Strychnine
33%
Forensic Toxicology
33%
Duragesic
33%
Clinical Toxicology
33%
Procaine
33%
Diseases
33%
Immunology and Microbiology
Heroin
100%
Low Drug Dose
33%
Clostridium
33%